ME/CFS and Long COVID share similar symptoms and biological abnormalities: road map to the literature

Front Med (Lausanne). 2023 Jun 2:10:1187163. doi: 10.3389/fmed.2023.1187163. eCollection 2023.

Abstract

Some patients remain unwell for months after "recovering" from acute COVID-19. They develop persistent fatigue, cognitive problems, headaches, disrupted sleep, myalgias and arthralgias, post-exertional malaise, orthostatic intolerance and other symptoms that greatly interfere with their ability to function and that can leave some people housebound and disabled. The illness (Long COVID) is similar to myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) as well as to persisting illnesses that can follow a wide variety of other infectious agents and following major traumatic injury. Together, these illnesses are projected to cost the U.S. trillions of dollars. In this review, we first compare the symptoms of ME/CFS and Long COVID, noting the considerable similarities and the few differences. We then compare in extensive detail the underlying pathophysiology of these two conditions, focusing on abnormalities of the central and autonomic nervous system, lungs, heart, vasculature, immune system, gut microbiome, energy metabolism and redox balance. This comparison highlights how strong the evidence is for each abnormality, in each illness, and helps to set priorities for future investigation. The review provides a current road map to the extensive literature on the underlying biology of both illnesses.

Keywords: Long COVID; chronic fatigue syndrome (CFS); myalgic encephalomyelitis (ME); myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS); post-acute sequelae of SARS-CoV-2 infection; post-infectious fatigue syndrome; post-intensive care unit syndrome.

Publication types

  • Review